Kelly M - Search Results

1

Effects of GLP-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta-analysis.

Kelly M, Lewis J, Rao H, Carter J, Portillo I, Beuttler R. Kelly M, et al. Pharmacotherapy. 2022 Dec;42(12):921-928. doi: 10.1002/phar.2737. Epub 2022 Nov 4. Pharmacotherapy. 2022. PMID: 36271706 Free PMC article. Review.

2

Evolving Role of Non-Statin Therapy for the Management of Dyslipidemia and Cardiovascular Risk Reduction: Past, Present, and Future.

Sisson EM, Pamulapati L, Bucheit JD, Kelly MS, Dixon DL. Sisson EM, et al. Among authors: kelly ms. Pharmacotherapy. 2018 Feb;38(2):164-171. doi: 10.1002/phar.2074. Epub 2018 Jan 10. Pharmacotherapy. 2018. PMID: 29266309 Free article. Review. No abstract available.

3

Efficacy and renal outcomes of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease.

Kelly MS, Lewis J, Huntsberry AM, Dea L, Portillo I. Kelly MS, et al. Postgrad Med. 2019 Jan;131(1):31-42. doi: 10.1080/00325481.2019.1549459. Epub 2018 Nov 30. Postgrad Med. 2019. PMID: 30449220 Free article. Review.

4

An update on dapagliflozin for chronic kidney disease.

Kelly MS. Kelly MS. Drugs Today (Barc). 2022 Feb;58(2):69-75. doi: 10.1358/dot.2022.58.2.3369188. Drugs Today (Barc). 2022. PMID: 35188141

5

Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies.

Alhomoud IS, Talasaz A, Mehta A, Kelly MS, Sisson EM, Bucheit JD, Brown R, Dixon DL. Alhomoud IS, et al. Among authors: kelly ms. Pharmacotherapy. 2023 Oct;43(10):1051-1063. doi: 10.1002/phar.2851. Epub 2023 Jul 26. Pharmacotherapy. 2023. PMID: 37464942 Review.

6

Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus.

Kelly MS, Scopelliti EM, Goodson KE, Lo CMA, Nguyen HX, Simon B. Kelly MS, et al. Diabetes Obes Metab. 2024 Dec;26(12):5661-5668. doi: 10.1111/dom.15934. Epub 2024 Sep 9. Diabetes Obes Metab. 2024. PMID: 39248221

7

Effectiveness of Pharmacist-Led Amiodarone Monitoring Services on Improving Adherence to Amiodarone Monitoring Recommendations: A Systematic Review.

Dixon DL, Dunn SP, Kelly MS, McLlarky TR, Brown RE. Dixon DL, et al. Pharmacotherapy. 2016 Feb;36(2):230-6. doi: 10.1002/phar.1697. Epub 2016 Feb 5. Pharmacotherapy. 2016. PMID: 26846446 Review.

8

Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis.

Baker WL, Buckley LF, Kelly MS, Bucheit JD, Parod ED, Brown R, Carbone S, Abbate A, Dixon DL. Baker WL, et al. J Am Heart Assoc. 2017 May 18;6(5):e005686. doi: 10.1161/JAHA.117.005686. J Am Heart Assoc. 2017. PMID: 28522675 Free PMC article. Review.

9

Efficacy and Safety of a Polypill to Reduce Cardiovascular Events: A Review of Clinical Trials.

Kelly MS, Dacey A, Siana A, Ojeda J. Kelly MS, et al. J Cardiovasc Pharmacol. 2024 Jan 1;83(1):8-15. doi: 10.1097/FJC.0000000000001508. J Cardiovasc Pharmacol. 2024. PMID: 37924288 Review.

10

Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature.

Elkomos M, Jahromi R, Kelly MS. Elkomos M, et al. Among authors: kelly ms. Pharmacy (Basel). 2022 Jan 7;10(1):13. doi: 10.3390/pharmacy10010013. Pharmacy (Basel). 2022. PMID: 35076632 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,602 results

Search Page

Filters